Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

Study Sheds Light On How A Brain On Ayahuasca Looks

A new study, led by a group at Imperial College London, revealed the most advanced-to-date brain images of the effects of the psychedelic compound DMT.

The trial monitored the brain activity of 20 healthy volunteers receiving either a 20mg DMT injection or a placebo through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) before, during and after the psychedelic session.

The brain’s normal structures change their standard hierarchical modes towards a more fluid communication and connectivity between regions related to imagination, language, memory and other higher-level functions.

The Latest Moves On States With Reform Bills

The Psychedelic Medicine Political Action Committee (PAC) is the latest activist-formed organization focused on steering federal funding toward research, education and ultimately encouraging policymakers on both sides of the aisle to revise long-standing restrictions on these substances.

With the goal of raising $10 million in its first year, the new group is petitioning donors, including investors in the for-profit biotech space.

At the state level, this week’s highlights occurred in California, Missouri, Hawaii, Texas, Minnesota, Vermont, Nevada, Washington and New Hampshire

The Milestone Round

Each week, Benzinga learns about new clinical trials, compounds and potential treatments:

Meet some of the biggest names in the psychedelics VCs and EFTs scenario at the second edition of our Psychedelics Capital Conference at the Fontainebleau Miami Beach Hotel on April 13!

See Also: Last Week's Edition Of 'Psyched'

Psychedelics ETFs Weekly Performance From March 20-24

  • AdvisorShares Psychedelics PSIL opened Monday, March 20, at $1.74, lower than prior week’s opening at $1.87, yet confirming a descending trend since February. After a small peak achieved on Tuesday, March 21 ($1.82), Friday 24 closed at $1.78, almost identical to former Friday, March 17’s $1.79 and Friday, March 10’s at $1.81.
    For this ETF, the yearly price range was once set between $6.26 and $1.82, and after gradual changes is now set between $4.35 and $1.70.

  • The Elemental Advisors PSYK ETF PSYK opened Monday, March 20, at $16.49, following former Monday, March 13’s low opening at $16.55 considering Monday 6 opened at $17.65. Lowest number of the week was $16.20 on Wed. 22, after which the stock recovered and closed on Friday, March 24, at $16.43, almost identical to prior closing at $16.40. For this ETF, the yearly price range was set between $23.32 and $16.70, and now the lowest price has been adjusted to $16.10.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksPsychedelicsGuidanceRumorsFinancingOfferingsContractsLegalManagementGlobalMarketsAustralia PsychedelicsPsychedelic-Assisted TherapiesPsychedelics Investing
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!